Revvity outlines 2026 organic growth of 4% to 5% and adjusted EPS of $5.30 to $5.40, driven by diagnostics momentum and AI-linked demand (NYSE:RVTY)
· seekingalpha.com
Revvity (RVTY) Q2 2026 earnings call recap: raised FY organic growth and EPS guidance, AI-driven instrument backlog, tariff refund impact, and...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...